Viewing StudyNCT00117078



Ignite Creation Date: 2024-05-05 @ 11:42 AM
Last Modification Date: 2024-10-26 @ 9:12 AM
Study NCT ID: NCT00117078
Status: COMPLETED
Last Update Posted: 2008-09-30
First Post: 2005-06-30

Brief Title: Aranesp Monthly Preference Study - 2
Sponsor: Amgen
Organization: Amgen

Conditions & Keywords Data

Conditions:
Name
Kidney Disease
Keywords:
Name View
Patient preference Subject preference View
Q2W dosing Q4W dosing View
Kidney disease Renal CKD Chronic Kidney Disease View
CRI Chronic Renal Insufficiency Pre-dialysis Amgen View
Aranesp Darbepoetin alfa QW dosing View